Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CANSINO-BIOLOGICS-INC-59318312/news/Cansino-Biologics-Inc-gibt-den-Beginn-der-klinischen-Phase-I-Studie-und-den-Abschluss-der-ersten-Pa-45513377/?utm_source=whatsapp&utm_medium=social&utm_campaign=share